RTA3
Triple-pathway research peptide RTA3 for GLP-1, GIP, and glucagon receptor pathway studies in controlled laboratory models.
Intended use: Laboratory research and analytical purposes only. This material is not a drug, not a dietary supplement, not a cosmetic for consumer use, and not for administration to humans or animals.
Selected: 5mg · Single vial
Research chemicals only. By adding to cart you reaffirm laboratory / analytical use—not for human or animal use.
| Product type | Research chemical |
|---|---|
| CAS | 2381089-83-2 |
| Molecular formula | See COA |
| Molecular weight | See COA |
| Purity (typical) | ≥98% |
| Form | Lyophilized powder |
| Intended use | Laboratory research & analytical use only |
| Not for | Human or animal use; clinical, dietary, or household use |
RTA3 overview
RTA3 is a high-purity lyophilized research peptide for multi-receptor metabolic signaling work spanning GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptor pathways in vitro and in defined experimental systems. Structural and lot data ship with each COA. Research use only — not for human or animal use.
Background
Catalogued as research code RTA3 for triple-agonist pathway tools (GLP-1 / GIP / glucagon) with batch documentation and COA support.
Research focus areas
Investigators commonly examine RTA3 across the following experimental themes:
Storage (laboratory handling)
Store lyophilized research material frozen, dry, and protected from light unless the lot COA specifies otherwise. Any reconstitution or experimental protocol must follow your institution’s laboratory SOPs for research chemicals. AminosPure does not provide instructions for human or animal administration and does not sell products for those uses.
References
Reference literature is available upon request for institutional buyers.